Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Clinical trial NCT05819125 · TERMINATED

Trial details

NCT number: NCT05819125
Sponsor: Sanofi
Status: TERMINATED
Study type: OBSERVATIONAL

Venous Thromboembolism

Start date: 2023-04-25
Primary completion: 2023-12-15
Enrollment: 21000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.